News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunomedics, Inc. (IMMU) Announces Six Presentations at the Society of Nuclear Medicine and Molecular Imaging 2013 Annual Meeting


6/3/2013 9:05:25 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MORRIS PLAINS, N.J., June 3, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that 6 presentations, of which 3 are oral presentations, will be given at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 Annual Meeting, scheduled for June 8 - 12, 2013, in Vancouver, BC, Canada.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES